4/28/06 Update
The Nasdaq Biotech Index declined slightly for the week and as of its 4/28 close is up a mere .44% YTD (vs. 1.06% YTD at last week's close). The median YTD gain for all 40 Charity portfolios also continued its descent and closed the week at 4.7% (down from 8.4% at its 4/21 close).
Moving counter to the downtrend, RKRW's portfolio marched ahead for the week and our leader's YTD gain now stands at a gargantuan 57.5% (vs. 54.9% at its 4/21 close). Despite getting hurt last week, Wilder's portfolio remains in second place, now up 37.6% YTD (vs. 42.5% at its 4/21 close).
As of their 4/28 week's close, 11 of the 40 Charity portfolios were in the red YTD, but a majority (28) are still outperforming the Nasdaq Biotech Index.
Here's the Unofficial Top Ten list on 4/28/06:
4/28/06
Rank Name Total
1 RKRW 57,505
2 WILDER 37,614
3 CYRAN 31,841
4 BULBA 30,355
5 MIKE 20,277
6 GEORGE 16,025
7 JACK 15,539
8 MANNY 14,635
9 IJ 13,747
10 FILOF 13,589
(All corrections greatly appreciated.) |
